Benlysta
Benlysta (belimumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a B-lymphocyte stimulator. Benlysta is used together with other lupus medicines to treat active systemic lupus erythematosus (SLE).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER: GlaxoSmithKline (GSK) |
CLASS: Selective immunosuppressants |
WHAT IT TREATS: Systemic Lupus |
PRESCRIBED BY: Rheumatologists |
HOW ADMINISTERED: IV infusion or subcutaneous injection |
FREQUENCY: Every 2 weeks for 3 doses then every 4 weeks |
Length of infusion: About an hour |
FOR MORE INFORMATION: |